| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/15/2004 | CA2511012A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 07/15/2004 | CA2510884A1 Fluorescent proteins from copepoda species and methods for using same |
| 07/15/2004 | CA2510315A1 Antibodies against gpr64 and uses thereof |
| 07/15/2004 | CA2510314A1 Breast specific protein expressed in cancer and methods of use thereof |
| 07/15/2004 | CA2510311A1 Novel therapeutic targets in cancer |
| 07/15/2004 | CA2510087A1 Human monoclonal antibodies against interleukin 8 (il-8) |
| 07/15/2004 | CA2509999A1 Btl-ii nucleic acids, proteins, and antibodies |
| 07/15/2004 | CA2509495A1 Lymphotoxin beta receptor agents in combination with chemotherapeutic agents |
| 07/15/2004 | CA2506668A1 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor |
| 07/14/2004 | EP1437595A1 Orphan GPCR gene 115 for obesity indication |
| 07/14/2004 | EP1437414A2 A method for promoting biocatalyst diversity |
| 07/14/2004 | EP1437401A1 Oxidoreductase |
| 07/14/2004 | EP1437367A1 Antibody and use thereof |
| 07/14/2004 | EP1437364A2 Polypeptide binding to the androgen receptor and its potential use for treating breast cancer |
| 07/14/2004 | EP1437363A1 Drug transporter and use thereof |
| 07/14/2004 | EP1436624A1 A method of diagnosis and treatment and agents useful for same |
| 07/14/2004 | EP1436418A2 Transductin-1 and transductin-2 and applications to hereditary deafness |
| 07/14/2004 | EP1436394A1 Leafhopper ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 07/14/2004 | EP1436383A2 Secreted proteins |
| 07/14/2004 | EP1436331A1 Process for the production of egg yolk antibodies against organochlorine pesticides |
| 07/14/2004 | EP1436330A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 07/14/2004 | EP1436329A1 Anti-pdgf antibodies and methods for producing engineered antibodies |
| 07/14/2004 | EP1436327A1 Ee3-protein family and corresponding dna sequences |
| 07/14/2004 | EP1436315A2 Novel methods for introducing molecules into cells and vectors and compositions for use in such methods |
| 07/14/2004 | EP1436004A1 Crustaceans as production systems for therapeutic proteins |
| 07/14/2004 | EP1436003A2 Taci-immunoglobulin fusion proteins |
| 07/14/2004 | EP1436000A2 Treatment of non-solid mammalian tumors with vascular endothelial growth factor receptor antagonists |
| 07/14/2004 | EP1435989A1 Ptp1b inhibitors and ligands |
| 07/14/2004 | EP1435987A1 Method and composition for treating immune complex associated disorders |
| 07/14/2004 | EP1435981A2 Anti-tumor activity from reptile serum |
| 07/14/2004 | EP1248802B1 Soluble ctla4 mutant molecules and uses thereof |
| 07/14/2004 | EP0889907B1 MONOCLONAL ANTIBODIES BINDING HUMAN GROWTH HORMONE (hGH) |
| 07/14/2004 | CN1513059A Enzymes having alpha amylase activity and method of use thereof |
| 07/14/2004 | CN1513000A Anti-osteopontin antibody and use thereof |
| 07/14/2004 | CN1512895A Use of polyclonal immunoglobulins |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1511959A High efficiency system for screening T cell antigen expression peptide and preparing MHC-peptide polymer (MHC tetramer) |
| 07/14/2004 | CN1511850A Process for preparing MHC-peptide antibody polymer |
| 07/14/2004 | CN1511847A Ubiquitin-like molecule coming from human dendritic cell and its codnig sequence and use |
| 07/14/2004 | CN1511845A Candida albicans molecular companion gere and its use |
| 07/14/2004 | CN1511841A Homoeotic box gene 9Brn-1 from quail and its use |
| 07/14/2004 | CN1157410C Human g-protein coupled receptor (HETGQ 23) |
| 07/14/2004 | CN1157406C Novel, ATP-sensitive potassium-channel proteins and genes for the same |
| 07/13/2004 | US6762341 Treating asthma in animals; antiinflammatory/bronchodilator agents; drug screening |
| 07/13/2004 | US6762295 For the treatment or prevention of gastroduodenal disease associated heliobacter infections |
| 07/13/2004 | US6762284 Used for medical applications, including diagnosis and treatment cell growth disorders like restenosis and cancer |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762051 Methods of inhibiting helicobacter pylori |
| 07/13/2004 | US6762032 Compositions, assay kits, and methods for use related to a disease condition comprising multiple sclerosis and/or a pro-MS immune response |
| 07/13/2004 | US6762029 An isolated nucleic acid molecule that encodes the amino acid sequence, cell culturing, binding to antibody, non-human transgenic animal, antithrombotic drugs, treating cardiovascular diseases, genetic engineering |
| 07/13/2004 | US6762024 A polynucleic acid composition comprising of one polynucleic acid containing contiguous nucleotides corresponding to a nucleotide sequence from certain specific regions |
| 07/13/2004 | US6761891 Medicament for treating a manifested lyme disease |
| 07/13/2004 | US6761889 Adjusting affinity of fab 27/26 fragments/polypeptides generating improved ragweed-induced histamine release inhibition; bronchodilator agents |
| 07/13/2004 | US6761888 Passive immunization treatment of Alzheimer's disease |
| 07/13/2004 | CA2288913C Membrane system for controlled tissue regeneration in cases of diseases of the peridontium |
| 07/13/2004 | CA2202913C Antibody reagent for detecting dissecting aortic aneurysm and uses thereof |
| 07/13/2004 | CA2134080C Natural humain igm antibodies |
| 07/13/2004 | CA2131528C Methods and compositions for targeting the vasculature of solid tumors |
| 07/08/2004 | WO2004056875A1 Antibodies against pd-1 and uses therefor |
| 07/08/2004 | WO2004056874A2 Neuropilin-1 inhibitors |
| 07/08/2004 | WO2004056873A1 Increase of the immune response by substances influencing the function of natural killer cells |
| 07/08/2004 | WO2004056866A1 Asthma susceptibility locus |
| 07/08/2004 | WO2004056865A2 Method of modulation of interaction between receptor and ligand |
| 07/08/2004 | WO2004056862A2 Immunogenic compositions to the cck-b/gastrin receptor and methods for the treatment of tumors |
| 07/08/2004 | WO2004056851A1 Peptides mimicking vibrio cholerae o139 capsular polysaccharide and their use to elicit protective immune response |
| 07/08/2004 | WO2004056847A2 Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 07/08/2004 | WO2004056845A2 Method for the production of a t cell receptor (tcr) consisting of a single chain tcr (sctcr) and a tcr constant region |
| 07/08/2004 | WO2004056392A1 Pharmaceutical compositions having an effect on the proliferation of nk cells and a method using the same |
| 07/08/2004 | WO2004056391A1 A method of immunisation and agents useful for same |
| 07/08/2004 | WO2004056316A2 Vaccines against hiv-1 tat protein to generate neutralizing antibodies |
| 07/08/2004 | WO2004056312A2 Immunoglobulin variants and uses thereof |
| 07/08/2004 | WO2004056308A2 CHIMERIC AND HUMANIZED ANTIBODIES TO α5β1 INTEGRIN THAT MODULATE ANGIOGENESIS |
| 07/08/2004 | WO2004056307A2 Disease treatment via antimicrobial peptide inhibitors |
| 07/08/2004 | WO2004041997A9 Immunotherapy regimens in hiv-infected patients |
| 07/08/2004 | WO2004041179A3 Scavenger receptor b1 (cla-1) targeting for the treatment of infection, sepsis and inflammation |
| 07/08/2004 | WO2004035611A8 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 07/08/2004 | WO2004019866A3 Compositions and methods for treating cardiovascular disease |
| 07/08/2004 | WO2004009759A9 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 07/08/2004 | WO2004009758A3 Embryonic stem cell markers and uses thereof |
| 07/08/2004 | WO2004006853A3 Treatment and prophylaxis with 4-1bb-binding agents |
| 07/08/2004 | WO2003104421A3 Immunocapture and functional assay for mitochondrial f1/f0 atpase |
| 07/08/2004 | WO2003090676A3 Immunogenic agent therapy using plasmapheresis or exchange transfusion |
| 07/08/2004 | WO2003070192A3 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 07/08/2004 | WO2003066822A3 Truncated aggrecanase molecules |
| 07/08/2004 | WO2003065998A8 Immunoglobulin purification |
| 07/08/2004 | WO2003046204A8 Humanized collagen antibodies and related methods |
| 07/08/2004 | WO2002097060A3 Carbohydrate-associated proteins |
| 07/08/2004 | WO2001022916A3 Novel hev antigenic peptide and methods |
| 07/08/2004 | US20040133357 Humanized antibodies against vascular endothelial growth factor |
| 07/08/2004 | US20040133356 Three-dimensional model of a Fc region of an IgE antibody and uses thereof |
| 07/08/2004 | US20040132980 Humanized anti-CCR2 antibodies and methods of use therefor |
| 07/08/2004 | US20040132979 Using chromatographic support to isolate and enhance fluid fraction for therapeutic immunoglobulins; vaccines; immunotherapy |
| 07/08/2004 | US20040132680 Beta secretase transgenic organisms and methods of use thereof |
| 07/08/2004 | US20040132661 Therapeutic method for treating bone formation diseases |
| 07/08/2004 | US20040132660 PRO256 polypeptide; wound healing and anticarcinogenic agents; cardiovascular disorders, atherosclerosis, and cardiac hypertrophy treatment |
| 07/08/2004 | US20040132646 Identification of a novel glutamine transporter |
| 07/08/2004 | US20040132642 Methods of inhibiting metastasis or growth of a tumor cell |
| 07/08/2004 | US20040132173 Optical microarray apparatus comprised of immobilized cells for concurrent monitoring of responses to test compounds; rational drug design and screening |